Combining targeted therapies: practical issues to consider at the bench and bedside.
about
Sulforaphane potentiates RNA damage induced by different xenobioticsRisk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experienceTargeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer.Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.Adaptive designs for dual-agent phase I dose-escalation studies.MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.
P2860
Q28482480-A0493618-D03B-40DB-A5F6-6C7BC398E07EQ33399986-2C302150-A04E-4B00-B626-8674FB101772Q33873775-295F5E11-3D33-4038-A772-FE58B3F740EDQ34181861-CFC4D2C7-903C-4690-A155-6E491118EF12Q34664129-133CE2AF-0BCA-473A-8058-CB9BEEB357CEQ35889822-E237C123-622F-41E1-8696-5825EFCBA1ACQ37404400-67917B00-E359-40B8-A2E7-280E481FB501Q38090897-39D4E22F-41FF-440D-B6CC-75D07D87BA29Q39518813-2F6DA8FF-58E4-41D9-9BE5-9FD0CAFF66BCQ45887067-E1187A47-416E-40FD-8C6D-3A0E6F3031EBQ47145765-F094844A-6909-409F-A27B-906F07FE94FA
P2860
Combining targeted therapies: practical issues to consider at the bench and bedside.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Combining targeted therapies: practical issues to consider at the bench and bedside.
@ast
Combining targeted therapies: practical issues to consider at the bench and bedside.
@en
type
label
Combining targeted therapies: practical issues to consider at the bench and bedside.
@ast
Combining targeted therapies: practical issues to consider at the bench and bedside.
@en
prefLabel
Combining targeted therapies: practical issues to consider at the bench and bedside.
@ast
Combining targeted therapies: practical issues to consider at the bench and bedside.
@en
P2860
P1433
P1476
Combining targeted therapies: practical issues to consider at the bench and bedside.
@en
P2093
Jordi Rodon
Jose Perez
P2860
P356
10.1634/THEONCOLOGIST.2009-0117
P577
2010-01-15T00:00:00Z